SCHEMBL25820897

SCHEMBL25820897

Cc1ccc2nccc(Nc3cccc(NC(=O)c4cccc(Nc5ccccc5)c4)c3)c2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 8/20 0.68
DNMT3A Q9Y6K1 7/20 0.68
DNMT3L Q9UJW3 5/20 0.61
EHMT1 Q9H9B1 3/20 0.61
KCNK3 O14649 4/20 0.53
KCNK9 Q9NPC2 4/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
POLB P06746 1/20 0.53
BRAF P15056 1/20 0.52
KCNH2 Q12809 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
EGFR P00533 1/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
CLK1 P49759 1/20 0.48
MAPK14 Q16539 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25820561 1.00 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1KCNK3
SCHEMBL24010295 0.94 DNMT1 (0.62) DNMT1DNMT3ADNMT3LEHMT1KCNK3
SCHEMBL30290952 0.94 DNMT1 (0.62) DNMT1DNMT3ADNMT3LEHMT1KCNK3
SCHEMBL24006421 0.94 DNMT1 (0.62) DNMT1DNMT3ADNMT3LEHMT1KCNK3
SCHEMBL24010985 0.92 DNMT1 (0.60) DNMT1DNMT3ADNMT3LEHMT1KCNK3
SCHEMBL24006224 0.90 DNMT1 (0.69) DNMT1DNMT3ADNMT3LEHMT1KCNK3
SCHEMBL24003959 0.90 DNMT1 (0.69) DNMT1DNMT3ADNMT3LEHMT1KCNK3
SCHEMBL25819893 0.90 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1MEN1
SCHEMBL24010246 0.89 DNMT1 (0.59) DNMT1DNMT3ADNMT3LEHMT1KCNK3
SCHEMBL25819896 0.88 DNMT1 (0.69) DNMT1DNMT3ADNMT3LEHMT1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885DNMT3L 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.